Psykedeliske stoffer i behandling av angst, depresjon og avhengighet
Tor-Morten Kvam, Lowan H. Stewart, Ole A. Andreassen
Tidsskrift for Den norske legeforening January 1, 2018 DOI: 10.4045/tidsskr.17.1110 via OpenAlex
Summary
AI-generated from the abstractPsychedelic substances show promise in treating several mental disorders, but existing studies are small and face methodological challenges. Systematic clinical trials are needed to obtain solid evidence of effectiveness and to establish routines for monitoring possible side effects.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Humanities Gynecology Philosophy Political science Art |
| Citations | 15 |
| Key finding | Psychedelic substances show promise for treating mental disorders, but current evidence is limited by small study sizes and methodological issues. |
Abstract
Psykedeliske stoffer i behandling av flere psykiske lidelser har vist lovende resultater, men studiene er små og har metodologiske utfordringer. Det er behov for systematiske kliniske studier for å skaffe solid dokumentasjon for effekt og etablere rutiner for overvåkning av mulige bivirkninger.